X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (49) 49
Publication (12) 12
Book / eBook (4) 4
Newspaper Article (4) 4
Dissertation (2) 2
Book Chapter (1) 1
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (27) 27
female (26) 26
humans (26) 26
ovarian cancer (23) 23
oncology (20) 20
ovarian neoplasms - genetics (20) 20
middle aged (14) 14
mutation (14) 14
adult (13) 13
aged (13) 13
cancer (12) 12
chemotherapy (11) 11
tumors (11) 11
ovarian neoplasms - pathology (10) 10
genetic aspects (9) 9
ovarian neoplasms - drug therapy (9) 9
breast cancer (8) 8
aged, 80 and over (7) 7
brca1 (7) 7
carcinoma (7) 7
genes, brca1 (7) 7
genes, brca2 (7) 7
medical research (7) 7
multidisciplinary sciences (7) 7
neoplasm grading (7) 7
patients (7) 7
research (7) 7
brca1 protein - genetics (6) 6
care and treatment (6) 6
deoxyribonucleic acid--dna (6) 6
endocrine system diseases (6) 6
germ-line mutation (6) 6
women (6) 6
analysis (5) 5
article (5) 5
breast (5) 5
dna repair (5) 5
gene mutations (5) 5
medicine (5) 5
methylation (5) 5
neoplasm staging (5) 5
ovarian carcinoma (5) 5
prognosis (5) 5
risk (5) 5
survival (5) 5
antineoplastic agents - therapeutic use (4) 4
breast neoplasms - genetics (4) 4
carcinoma, ovarian epithelial (4) 4
copy number (4) 4
cyclin e - genetics (4) 4
cystadenocarcinoma, serous - genetics (4) 4
dna (4) 4
dna methylation (4) 4
evolution (4) 4
gene amplification (4) 4
gene expression (4) 4
genes (4) 4
genomes (4) 4
genomics (4) 4
male (4) 4
metastasis (4) 4
methods (4) 4
oncogene proteins - genetics (4) 4
oncology, experimental (4) 4
ovarian neoplasms - mortality (4) 4
pathology (4) 4
poly polymerase (4) 4
resistance (4) 4
science (4) 4
survival analysis (4) 4
treatment outcome (4) 4
variants (4) 4
autopsy (3) 3
brca1 protein (3) 3
brca2 protein - genetics (3) 3
cancer patients (3) 3
case-control studies (3) 3
cohort studies (3) 3
cystadenocarcinoma, serous - drug therapy (3) 3
development and progression (3) 3
dna-binding proteins - genetics (3) 3
drug resistance, neoplasm (3) 3
fallopian-tube (3) 3
family (3) 3
female genital diseases and pregnancy complications (3) 3
gene dosage (3) 3
gene expression regulation, neoplastic (3) 3
genetic predisposition to disease (3) 3
genetic research (3) 3
genetics (3) 3
genetics & heredity (3) 3
high-throughput nucleotide sequencing (3) 3
homologous recombination (3) 3
hospitals (3) 3
hybridization (3) 3
identification (3) 3
immunohistochemistry (3) 3
mutational processes (3) 3
mutations (3) 3
neoplasms, glandular and epithelial - genetics (3) 3
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (2) 2
Architecture Landscape (Shore + Moffat) - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Music - Circulation Desk (1) 1
Royal Ontario Museum - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 07/2012, Volume 30, Issue 21, pp. 2654 - 2663
Purpose The frequency of BRCA1 and BRCA2 germ-line mutations in women with ovarian cancer is unclear; reports vary from 3% to 27%. The impact of germ-line... 
POLY(ADP-RIBOSE) POLYMERASE | CLEAR-CELL | ONCOLOGY | RESISTANCE | IMPROVED SURVIVAL | HOMOLOGOUS RECOMBINATION | CARCINOMA | CARRIERS | TUMORS | CHEMOTHERAPY | FEATURES | Medical History Taking | Recurrence | Prospective Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Drug Resistance, Neoplasm | Cystadenocarcinoma, Serous - genetics | Cystadenocarcinoma, Serous - drug therapy | Case-Control Studies | Ovarian Neoplasms - genetics | Peritoneal Neoplasms - drug therapy | Neoplasm Grading | Fallopian Tube Neoplasms - genetics | Aged, 80 and over | Genes, BRCA2 | Germ-Line Mutation | Adult | Female | Genes, BRCA1 | Ovarian Neoplasms - drug therapy | Fallopian Tube Neoplasms - drug therapy | Carcinoma - drug therapy | Carcinoma, Endometrioid - genetics | Kaplan-Meier Estimate | Mutation Rate | Treatment Outcome | Carcinoma, Endometrioid - drug therapy | Australia - epidemiology | Ovarian Neoplasms - epidemiology | Disease-Free Survival | Point Mutation | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Peritoneal Neoplasms - genetics | Carcinoma - genetics | Aged | Platinum Compounds - administration & dosage | Neoplasm Staging | Adenocarcinoma, Clear Cell - genetics | Adenocarcinoma, Clear Cell - drug therapy | Cohort Studies | Original Reports | Gynecologic Cancer | Gync21 | Gync15
Journal Article
by Patch, Ann-Marie and Christie, Elizabeth L and Etemadmoghadam, Dariush and Garsed, Dale W and George, Joshy and Fereday, Sian and Nones, Katia and Cowin, Prue and Alsop, Kathryn and Bailey, Peter J and Kassahn, Karin S and Newell, Felicity and Quinn, Michael C.J and Kazakoff, Stephen and Quek, Kelly and Wilhelm-Benartzi, Charlotte and Curry, Ed and Leong, Huei San and Hamilton, Anne and Mileshkin, Linda and Au-Yeung, George and Kennedy, Catherine and Hung, Jillian and Chiew, Yoke-Eng and Harnett, Paul and Friedlander, Michael and Quinn, Michael and Pyman, Jan and Cordner, Stephen and O'Brien, Patricia and Leditschke, Jodie and Young, Greg and Strachan, Kate and Waring, Paul and Azar, Walid and Mitchell, Chris and Traficante, Nadia and Hendley, Joy and Thorne, Heather and Shackleton, Mark and Miller, David K and Arnau, Gisela Mir and Tothill, Richard W and Holloway, Timothy P and Semple, Timothy and Harliwong, Ivon and Nourse, Craig and Nourbakhsh, Ehsan and Manning, Suzanne and Idrisoglu, Senel and Bruxner, Timothy J. C and Christ, Angelika N and Poudel, Barsha and Holmes, Oliver and Anderson, Matthew and Leonard, Conrad and Lonie, Andrew and Hall, Nathan and Wood, Scott and Taylor, Darrin F and Xu, Qinying and Lynn Fink, J and Waddell, Nick and Drapkin, Ronny and Stronach, Euan and Gabra, Hani and Brown, Robert and Jewell, Andrea and Nagaraj, Shivashankar H and Markham, Emma and Wilson, Peter J and Ellul, Jason and McNally, Orla and Doyle, Maria A and Vedururu, Ravikiran and Stewart, Collin and Lengyel, Ernst and Pearson, John V and Waddell, Nicola and Defazio, Anna and Grimmond, Sean M and Bowtell, David D. L and Australian Ovarian Canc Study Grp and Australian Ovarian Cancer Study Group and The Australian Ovarian Cancer Study Group
Nature, ISSN 0028-0836, 05/2015, Volume 521, Issue 7553, pp. 489 - 494
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2013, Volume 110, Issue 48, pp. 19489 - 19494
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2012, Volume 18, Issue 20, pp. 5806 - 5815
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2009, Volume 15, Issue 4, pp. 1417 - 1427
Journal Article
Nature Communications, ISSN 2041-1723, 12/2019, Volume 10, Issue 1, pp. 1295 - 10
ABCB1 encodes Multidrug Resistance protein (MDR1), an ATP-binding cassette member involved in the cellular efflux of chemotherapeutic drugs. Here we report... 
ALIGNER | MULTIDISCIPLINARY SCIENCES | CHEMOTHERAPY RESISTANCE | Efflux | Ovarian carcinoma | Transcription | Multidrug resistance | Poly(ADP-ribose) polymerase | Substrate inhibition | Breast cancer | Cell fusion | Drug resistance | Patients | Substrates | Gene fusion | Ovarian cancer | Proteins | MDR1 protein | Chemotherapy | Paclitaxel | P-Glycoprotein | Cancer
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2018, Volume 24, Issue 3, pp. 569 - 580
Journal Article
by Kondrashova, Olga and Topp, Monique and Nesic, Ksenija and Lieschke, Elizabeth and Ho, Gwo-Yaw and Harrell, Maria I and Zapparoli, Giada V and Hadley, Alison and Holian, Robert and Boehm, Emma and Heong, Valerie and Sanij, Elaine and Pearson, Richard B and Krais, John J and Johnson, Neil and McNally, Orla and Ananda, Sumitra and Alsop, Kathryn and Hutt, Karla J and Kaufmann, Scott H and Lin, Kevin K and Harding, Thomas C and Traficante, Nadia and Chenevix-Trench, G and Green, A and Webb, P and Gertig, D and Fereday, S and Moore, S and Hung, J and Harrap, K and Sadkowsky, T and Pandeya, N and Malt, M and Mellon, A and Robertson, R and Vanden Bergh, T and Jones, M and Mackenzie, P and Maidens, J and Nattress, K and Chiew, Y.E and Stenlake, A and Sullivan, H and Alexander, B and Ashover, P and Brown, S and Corrish, T and Green, L and Jackman, L and Ferguson, K and Martin, K and Martyn, A and Ranieri, B and White, J and Jayde, V and Mamers, P and Bowes, L and Galletta, L and Giles, D and Hendley, J and Schmidt, T and Shirley, H and Ball, C and Young, C and Viduka, S and Tran, H and Bilic, S and Glavinas, L and Brooks, J and Stuart-Harris, R and Kirsten, F and Rutovitz, J and Clingan, P and Glasgow, A and Proietto, A and Braye, S and Otton, G and Shannon, J and Bonaventura, T and Stewart, J and Begbie, S and Friedlander, M and Bell, D and Baron-Hay, S and Ferrier, A and Gard, G and Nevell, D and Pavlakis, N and Valmadre, S and Young, B and Camaris, C and Crouch, R and Edwards, L and Hacker, N and Marsden, D and Robertson, G and Beale, P and Beith, J and Carter, J and ... and Australian Ovarian Cancer Study (AOCS)
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 3970 - 16
Journal Article
by Ramus, Susan J and Ramus, Susan J and Song, Honglin and Song, Honglin and Dicks, Ed and Dicks, Ed and Tyrer, Jonathan P and Tyrer, Jonathan P and Rosenthal, Adam N and Rosenthal, Adam N and Intermaggio, Maria P and Intermaggio, Maria P and Fraser, Lindsay and Fraser, Lindsay and Gentry-Maharaj, Aleksandra and Gentry-Maharaj, Aleksandra and Hayward, Jane and Hayward, Jane and Philpott, Susan and Philpott, Susan and Anderson, Christopher and Anderson, Christopher and Edlund, Christopher K and Edlund, Christopher K and Conti, David and Conti, David and Harrington, Patricia and Harrington, Patricia and Barrowdale, Daniel and Barrowdale, Daniel and Bowtell, David D and Bowtell, David D and Alsop, Kathryn and Alsop, Kathryn and Mitchell, Gillian and Mitchell, Gillian and Cicek, Mine S and Cunningham, Julie M and Cicek, Mine S and Fridley, Brooke L and Cunningham, Julie M and Fridley, Brooke L and Alsop, Jennifer and Alsop, Jennifer and Jimenez-Linan, Mercedes and Jimenez-Linan, Mercedes and Poblete, Samantha and Lele, Shashi and Poblete, Samantha and Lele, Shashi and Sucheston-Campbell, Lara and Sucheston-Campbell, Lara and Moysich, Kirsten B and Sieh, Weiva and Moysich, Kirsten B and Sieh, Weiva and McGuire, Valerie and McGuire, Valerie and Lester, Jenny and Lester, Jenny and Bogdanova, Natalia and Bogdanova, Natalia and Dürst, Matthias and Hillemanns, Peter and Dürst, Matthias and Odunsi, Kunle and Hillemanns, Peter and Whittemore, Alice S and Karlan, Beth Y and Odunsi, Kunle and Dörk, Thilo and Whittemore, Alice S and Karlan, Beth Y and Goode, Ellen L and Dörk, Thilo and Menon, Usha and Goode, Ellen L and Jacobs, Ian J and Menon, Usha and Antoniou, Antonis C and Pharoah, Paul D. P and Jacobs, Ian J and Gayther, Simon A and Antoniou, Antonis C and Pharoah, Paul D. P and Gayther, Simon A and Ovarian Canc Assoc Consortium and AOCS Study Grp and AOCS Study Group and Ovarian Cancer Association Consortium
Journal of the National Cancer Institute, ISSN 0027-8874, 11/2015, Volume 107, Issue 11, p. 1
Journal Article